Seres Therapeutics (MCRB) Interest Coverage Ratio (2014 - 2026)
Seres Therapeutics (MCRB) posted Interest Coverage Ratio of 4.2 for Q1 2026, down 2202.0% sequentially from 0.18 in Q3 2025, and up 24.84% YoY from 3.36 in Q1 2025.
Seres Therapeutics (MCRB) Interest Coverage Ratio (2014 - 2026) Analysis & Trends
Seres Therapeutics has reported Interest Coverage Ratio for 13 years, with the latest figure at 4.2 in Q1 2026.
- Quarterly Interest Coverage Ratio rose 24.84% year-over-year to 4.2 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 5.37 (down 3.81% YoY) and the FY2025 annual result came in at 0.3, up 22.84% from the prior year.
- Interest Coverage Ratio fell to 4.2 in Q1 2026 per MCRB's latest filing, from 0.18 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 7.25 in Q2 2023 and troughed at 26.38 in Q1 2022.
- A 5-year average of 5.55 and a median of 4.33 in 2024 frame the typical range for Interest Coverage Ratio.
- The widest YoY moves for Interest Coverage Ratio: up 9882.99% in 2023, down 281364.59% in 2023.
- Over 5 years, Interest Coverage Ratio stood at 0.03 in 2022, then tumbled by 12637.36% to 3.67 in 2023, then slipped by 21.29% to 4.46 in 2024, then surged by 95.91% to 0.18 in 2025, then slumped by 2202.0% to 4.2 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 4.2, 0.18, and 0.19 for Q1 2026, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Seres Therapeutics | 43.87 Mn | 43.87 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.28 |
| Mar 31, 2026 | -4.20 |
| Sep 30, 2025 | -0.18 |
| Jun 30, 2025 | -0.19 |
| Mar 31, 2025 | -5.58 |
| Dec 31, 2024 | -4.46 |
| Sep 30, 2024 | -5.44 |
| Jun 30, 2024 | -5.39 |
| Mar 31, 2024 | -9.58 |
| Dec 31, 2023 | -3.67 |
| Sep 30, 2023 | -10.14 |
| Jun 30, 2023 | 7.25 |
| Mar 31, 2023 | -20.68 |
| Dec 31, 2022 | -0.03 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | -0.07 |
| Mar 31, 2022 | -26.38 |
| Dec 31, 2021 | -66.98 |
| Sep 30, 2021 | 0.00 |
| Jun 30, 2021 | -0.34 |